Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC
Conditions
- Carcinoma, Non-Small-Cell Lung
- Neoplasm Metastasis
Interventions
- DRUG: Erlotinib, Temozolomide
Sponsor
Tel-Aviv Sourasky Medical Center
Collaborators